BioVie Inc.
BIVI
$7.14
-$0.43-5.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.99M | -24.27M | -25.56M | -32.12M | -36.29M |
| Total Depreciation and Amortization | 229.20K | 229.20K | 229.20K | 229.20K | 229.20K |
| Total Amortization of Deferred Charges | 28.40K | 827.30K | 855.60K | 883.90K | 910.00K |
| Total Other Non-Cash Items | 3.68M | 3.41M | 3.02M | 3.15M | 528.70K |
| Change in Net Operating Assets | -2.37M | -2.22M | 2.11M | -86.90K | -602.50K |
| Cash from Operations | -17.42M | -22.02M | -19.35M | -27.95M | -35.23M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 14.53M | 12.73M |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 14.53M | 12.73M |
| Total Debt Issued | 2.90M | -- | -- | -- | -- |
| Total Debt Repaid | -8.35M | -10.85M | -10.00M | -10.00M | -7.50M |
| Issuance of Common Stock | 18.58M | 37.05M | 28.16M | 27.80M | 29.07M |
| Repurchase of Common Stock | -2.90M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.23M | 26.20M | 18.16M | 17.80M | 21.57M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.20M | 4.18M | -1.19M | 4.38M | -925.90K |